Correlation Between DiaMedica Therapeutics and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and AN2 Therapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and AN2 Therapeutics.
Diversification Opportunities for DiaMedica Therapeutics and AN2 Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between DiaMedica and AN2 is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and AN2 Therapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.68 times more return on investment than AN2 Therapeutics. However, DiaMedica Therapeutics is 1.47 times less risky than AN2 Therapeutics. It trades about 0.08 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 144.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 422.00 from holding DiaMedica Therapeutics or generate 293.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. AN2 Therapeutics
Performance |
| Timeline |
| DiaMedica Therapeutics |
| AN2 Therapeutics |
DiaMedica Therapeutics and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and AN2 Therapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| AN2 Therapeutics vs. DiaMedica Therapeutics | AN2 Therapeutics vs. Lyra Therapeutics | AN2 Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |